Repository logo
 
Publication

Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report

2018-06Journal article Open access
Simple item page
dc.contributor.authorMarques da Silva, P
dc.contributor.authorSequeira Duarte, J
dc.contributor.authorvon Hafe, P
dc.contributor.authorGil, V
dc.contributor.authorNunes de Oliveira, J
dc.contributor.authorde Sousa, G
dc.date.accessioned2019-11-22T16:40:25Z
dc.date.available2019-11-22T16:40:25Z
dc.date.issued2018-06
dc.description.abstractEven with the improvement in lifestyle interventions, a better control of cardiovascular (CV) risk factors, and improvements in CV outcomes, cardiovascular disease (CVD) still persists as the leading cause of morbidity and mortality in Portugal and Europe. Atherogenic dyslipidaemias, namely hypercholesterolaemia, have a crucial and causal role in the development of atherosclerotic CVD. The clinical approach of a patient with dyslipidaemia involves a watchful diagnosis, sustained in lipid and lipoprotein laboratory procedures, which must be harmonized and standardized. Standardization of lipid test results and reports, incorporating the total CV risk and the respective target and goals of treatment approach, guarantees that clinical guidelines and good clinical practices are followed and respected, increasing the reliability of lipid disorders screening, producing more accurate diagnoses and CV risk stratification, and improving the CV prevention and the achievement the desirable treatment goals.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationAtheroscler Suppl. 2018 Jun;31:e1-e12.pt_PT
dc.identifier.doi10.1016/j.atherosclerosissup.2018.04.001pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3365
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.subjectBiomarkerspt_PT
dc.subjectBlood Chemical Analysispt_PT
dc.subjectCardiovascular Diseasespt_PT
dc.subjectConsensuspt_PT
dc.subjectDyslipidemiaspt_PT
dc.subjectFastingpt_PT
dc.subjectHumanspt_PT
dc.subjectLipidspt_PT
dc.subjectLipoproteinspt_PT
dc.subjectPortugalpt_PT
dc.subjectPredictive Value of Testspt_PT
dc.subjectPrognosispt_PT
dc.subjectReproducibility of Resultspt_PT
dc.subjectRisk Assessmentpt_PT
dc.subjectRisk Factorspt_PT
dc.subjectHSM MEDpt_PT
dc.titleStandardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Reportpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPagee12pt_PT
oaire.citation.startPagee1pt_PT
oaire.citation.titleAtherosclerosis. Supplementspt_PT
oaire.citation.volume31pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Atheroscl Suppl.pdf
Size:
743 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

MED - Artigos